Review discusses metabolic reprogramming of T cells

by Cactus CommunicationsT cell immunotherapy can be optimized by understanding the metabolism of T cells. This review article summarizes the intricacies of effector and memory T cell metabolic reprogr

Updated on: March 07,2024 12

Review discusses metabolic reprogramming of T cells

by Cactus CommunicationsT cell immunotherapy can be optimized by understanding the metabolism of T cells. This review article summarizes the intricacies of effector and memory T cell metabolic reprogr

Updated on:March 07,2024 12

Weekly Update of Drug News-23/12/2024

Weekly update of drug news.

Updated on: December 27,2024 0

Weekly Update of Drug News-23/12/2024

Weekly update of drug news.

Updated on:December 27,2024 0

Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants, study finds

by Perelman School of Medicine at the University of PennsylvaniaGraphical abstract. Credit:Immunity(2024). DOI: 10.1016/j.immuni.2024.02.017A new study from the Perelman School of Med

Updated on: March 19,2024 13

Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants, study finds

by Perelman School of Medicine at the University of PennsylvaniaGraphical abstract. Credit:Immunity(2024). DOI: 10.1016/j.immuni.2024.02.017A new study from the Perelman School of Med

Updated on:March 19,2024 13

More research needed to determine safety of hip and knee steroid injections

by Boston University School of MedicineCredit: CC0 Public DomainAlthough frequently used to treat painful osteoarthritis of the hip and knee, intra-articular corticosteroid (IACS) injections rema

Updated on: May 26,2024 6

More research needed to determine safety of hip and knee steroid injections

by Boston University School of MedicineCredit: CC0 Public DomainAlthough frequently used to treat painful osteoarthritis of the hip and knee, intra-articular corticosteroid (IACS) injections rema

Updated on:May 26,2024 6

Groundbreaking study reveals clues to predict mortality in rare VEXAS syndrome

by American College of RheumatologyHematopoietic precursor cells: promyelocyte in the center, two metamyelocytes next to it and band cells from a bone marrow aspirate. Credit: Bobjgalindo/Wikiped

Updated on: May 23,2024 4

Groundbreaking study reveals clues to predict mortality in rare VEXAS syndrome

by American College of RheumatologyHematopoietic precursor cells: promyelocyte in the center, two metamyelocytes next to it and band cells from a bone marrow aspirate. Credit: Bobjgalindo/Wikiped

Updated on:May 23,2024 4

St18 is a negative regulator of VEGF

by National Institutes of Natural SciencesSt18 inhibits VEGF expression via Sp1 suppression. Credit: Kenta MaruyamaPro-inflammatory cytokines and pathogen-associated molecular patterns such as lipopol

Updated on: April 22,2024 15

St18 is a negative regulator of VEGF

by National Institutes of Natural SciencesSt18 inhibits VEGF expression via Sp1 suppression. Credit: Kenta MaruyamaPro-inflammatory cytokines and pathogen-associated molecular patterns such as lipopol

Updated on:April 22,2024 15

This gross mixture has big benefits for the study of bacteria

byUniversity of MichiganDetermining the bottleneck of infection forP. mirabilisduring UTI. (A–C) CBA/J mice were transurethrally inoculated with 107CFU. The inoculum contained

Updated on: January 25,2024 17

This gross mixture has big benefits for the study of bacteria

byUniversity of MichiganDetermining the bottleneck of infection forP. mirabilisduring UTI. (A–C) CBA/J mice were transurethrally inoculated with 107CFU. The inoculum contained

Updated on:January 25,2024 17

Peresolimab found to be efficacious for rheumatoid arthritis

by Elana GotkinePeresolimab, a humanized immunoglobulin G1 monoclonal antibody designed to stimulate the endogenous programmed cell death protein 1 (PD-1) inhibitory pathway, is efficacious for patien

Updated on: June 28,2024 5

Peresolimab found to be efficacious for rheumatoid arthritis

by Elana GotkinePeresolimab, a humanized immunoglobulin G1 monoclonal antibody designed to stimulate the endogenous programmed cell death protein 1 (PD-1) inhibitory pathway, is efficacious for patien

Updated on:June 28,2024 5

A new drug promises to lower risks of asthma attack

by Himanshu Kaul,The ConversationCredit: CC0 Public DomainArecent studyshows that a gamechanger drug called Fevipiprantpromises to lower patients' risks of suffering an ast

Updated on: March 25,2024 16

A new drug promises to lower risks of asthma attack

by Himanshu Kaul,The ConversationCredit: CC0 Public DomainArecent studyshows that a gamechanger drug called Fevipiprantpromises to lower patients' risks of suffering an ast

Updated on:March 25,2024 16

Review highlights the challenges and recent advances in targeted therapies for lupus nephritis

by Cactus CommunicationsSLE involves abnormal activation of both innate and adaptive immune responses, leading to systemic immune dysregulation and renal impairment. The complement system's dysfun

Updated on: January 26,2024 13

Review highlights the challenges and recent advances in targeted therapies for lupus nephritis

by Cactus CommunicationsSLE involves abnormal activation of both innate and adaptive immune responses, leading to systemic immune dysregulation and renal impairment. The complement system's dysfun

Updated on:January 26,2024 13

Screening and treating infections in AIIRD

by European Alliance of Associations for Rheumatology (EULAR)Typical screening for hepatitis B virus (HBV) status include HBsAg, anti-HBcore and anti-HBs. HBsAg-positive patients (HBV carriers) would

Updated on: May 26,2024 7

Screening and treating infections in AIIRD

by European Alliance of Associations for Rheumatology (EULAR)Typical screening for hepatitis B virus (HBV) status include HBsAg, anti-HBcore and anti-HBs. HBsAg-positive patients (HBV carriers) would

Updated on:May 26,2024 7

Trial data underpins FDA approval of omalizumab for food allergy

by NIH/National Institute of Allergy and Infectious DiseasesCredit: Unsplash/CC0 Public DomainToday's Food and Drug Administration approval of a supplemental biologics license for the monoclo

Updated on: May 07,2024 11

Trial data underpins FDA approval of omalizumab for food allergy

by NIH/National Institute of Allergy and Infectious DiseasesCredit: Unsplash/CC0 Public DomainToday's Food and Drug Administration approval of a supplemental biologics license for the monoclo

Updated on:May 07,2024 11